BRPI0513145A - conjugados de amino, aminoácido ou peptìdeo de ácido retinóico - Google Patents

conjugados de amino, aminoácido ou peptìdeo de ácido retinóico

Info

Publication number
BRPI0513145A
BRPI0513145A BRPI0513145-6A BRPI0513145A BRPI0513145A BR PI0513145 A BRPI0513145 A BR PI0513145A BR PI0513145 A BRPI0513145 A BR PI0513145A BR PI0513145 A BRPI0513145 A BR PI0513145A
Authority
BR
Brazil
Prior art keywords
amino
acid
peptide conjugates
retinoic acid
retinoic
Prior art date
Application number
BRPI0513145-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Raphael Beumer
Jochen Klock
Juergen H Vollhardt
Philippe Emmanuel Maillan
Stefan Stoeckli
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of BRPI0513145A publication Critical patent/BRPI0513145A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/20Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BRPI0513145-6A 2004-07-09 2005-07-01 conjugados de amino, aminoácido ou peptìdeo de ácido retinóico BRPI0513145A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04016239 2004-07-09
PCT/EP2005/007134 WO2006005455A2 (en) 2004-07-09 2005-07-01 Amino, amino acid or peptide conjugates of retinoic acid

Publications (1)

Publication Number Publication Date
BRPI0513145A true BRPI0513145A (pt) 2008-04-29

Family

ID=35062952

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513145-6A BRPI0513145A (pt) 2004-07-09 2005-07-01 conjugados de amino, aminoácido ou peptìdeo de ácido retinóico

Country Status (7)

Country Link
US (1) US20070270472A1 (https=)
EP (1) EP1765773A2 (https=)
JP (1) JP2008515770A (https=)
KR (1) KR20070038509A (https=)
CN (1) CN101048375B (https=)
BR (1) BRPI0513145A (https=)
WO (1) WO2006005455A2 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5572318B2 (ja) * 2005-12-30 2014-08-13 ルバンス セラピュティックス インク. 局所投与用アルギニンヘテロマー
US20100222275A1 (en) * 2007-10-19 2010-09-02 Kunihiko Tamaki Therapeutic agent for vitiligo and method of accelerating pigmentation
KR101740353B1 (ko) * 2009-09-29 2017-05-26 가부시키가이샤 시세이도 항산화 조성물
JP5864615B2 (ja) * 2011-01-25 2016-02-17 ザ プロクター アンド ギャンブルカンパニー リポソーム及びそれを含むパーソナルケア組成物
KR101224809B1 (ko) * 2012-04-24 2013-01-21 주식회사 아이피어리스 레티노산 유도체, 이의 제조 방법 및 이를 포함하는 화장품 조성물
EP2745904B1 (en) 2012-12-21 2015-12-16 Dionex Corporation HILIC/Anion-Exchange/Cation-Exchange Multimodal Media
US9511144B2 (en) 2013-03-14 2016-12-06 The Proctor & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
WO2015023926A1 (en) * 2013-08-15 2015-02-19 Mary Kay Inc. Topical skin compositions for treating wrinkles
FR3054130B1 (fr) 2016-07-22 2019-04-26 Syntivia Procede de traitement cosmetique de la peau
KR102093209B1 (ko) * 2017-05-11 2020-03-25 (주)케어젠 이소트레티노인과 펩타이드의 결합체
US11148998B2 (en) 2017-05-23 2021-10-19 The Regents Of The University Of Michigan Dimethyl-nonatetraenyl-trimethyl-cyclohexyl compounds and uses thereof
WO2018237218A1 (en) 2017-06-23 2018-12-27 The Procter & Gamble Company COMPOSITION AND METHOD FOR ENHANCING SKIN APPEARANCE
KR20210011964A (ko) 2018-07-03 2021-02-02 더 프록터 앤드 갬블 캄파니 피부 병태를 치료하는 방법
KR102076178B1 (ko) * 2018-07-18 2020-02-11 주식회사 코리아나화장품 초유 및 오르니틴을 유효성분으로 함유하는 피부 주름 개선용 화장료 조성물
KR20210092483A (ko) 2020-01-16 2021-07-26 맹창남 모발 및 두피상태 개선용 화장료 조성물
CN115843238B (zh) 2020-06-01 2025-06-10 宝洁公司 改善维生素b3化合物渗透到皮肤中的方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
CN117384073A (zh) * 2022-07-11 2024-01-12 南京毓浠医药技术有限公司 一种维a酸醇胺类复合物及其制备方法和应用
CN118121574A (zh) * 2022-12-02 2024-06-04 南京毓浠医药技术有限公司 一种含维a酸组合物及其制备方法和用途
KR20250136628A (ko) 2024-03-08 2025-09-16 주식회사 에이치엔컴퍼니 모발 개선용 화장료 조성물
CN118126119B (zh) * 2024-05-10 2024-08-06 荷本世新(北京)生物科技有限公司 维a酸多肽衍生物及其制备方法和用途
CN121517355A (zh) * 2026-01-15 2026-02-13 珀莱雅化妆品股份有限公司 一种吡哆胺衍生物、制备方法及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH529742A (de) * 1970-02-02 1972-10-31 Hoffmann La Roche Verfahren zur Herstellung von Vitamin-A-Säureamiden
US3950418A (en) * 1970-02-02 1976-04-13 Hoffmann-La Roche Inc. Vitamin A acid amides
DE2300107C2 (de) * 1973-01-03 1982-03-11 Basf Ag, 6700 Ludwigshafen Vitamin A-Säureanilid-4-carbonsäureäthylester, Verfahren zu seiner Herstellung und diesen enthaltende Zubereitungen
US4108880A (en) * 1975-11-03 1978-08-22 Johnson & Johnson Esters of retinoic acid
CH661516A5 (de) * 1983-12-08 1987-07-31 Hoffmann La Roche Phenylnonatetraenoylzuckerderivate.
US5559149A (en) * 1990-01-29 1996-09-24 Johnson & Johnson Consumer Products, Inc. Skin care compositions containing retinoids
DE4032187C2 (de) * 1990-10-10 1995-03-30 Gradinger F Hermes Pharma N-Retinoyl-L-aminomercapto-Verbindungen und Zwischenprodukte, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19523079A1 (de) * 1995-06-26 1997-01-02 Basf Ag Ester und Amide der 9(Z)-Retinsäure
ATE239701T1 (de) * 1998-03-30 2003-05-15 Lg Chemical Ltd Polyethoxylierte retinamid-derivate und verfahren zu ihrer herstellung
JP4646408B2 (ja) * 1999-03-02 2011-03-09 協和発酵バイオ株式会社 化粧料
JP2001039997A (ja) * 1999-07-29 2001-02-13 Lion Corp 安定化されたレチノイン酸類の誘導体、ならびにそれらを含有する外用剤組成物
JP4221547B2 (ja) * 2001-01-26 2009-02-12 ライオン株式会社 レチノイン酸類またはその誘導体を含有する組成物
KR100439627B1 (ko) * 2001-06-18 2004-07-12 주식회사 엘지생활건강 피부주름 예방 및 치료용 조성물
WO2004010966A1 (ja) * 2002-07-25 2004-02-05 Lion Corporation 外用剤組成物
CN1197847C (zh) * 2002-09-02 2005-04-20 复旦大学 化合物n-全反式维甲酰胺衍生物及其制备方法和应用
EP1686957B1 (en) * 2003-11-17 2012-03-07 Sederma Compositions containing mixtures of tetrapeptides and tripeptides

Also Published As

Publication number Publication date
WO2006005455A2 (en) 2006-01-19
EP1765773A2 (en) 2007-03-28
CN101048375B (zh) 2012-12-05
WO2006005455A3 (en) 2008-02-07
CN101048375A (zh) 2007-10-03
KR20070038509A (ko) 2007-04-10
JP2008515770A (ja) 2008-05-15
US20070270472A1 (en) 2007-11-22

Similar Documents

Publication Publication Date Title
BRPI0513145A (pt) conjugados de amino, aminoácido ou peptìdeo de ácido retinóico
BRPI0816214B8 (pt) uso cosmético, composição cosmética e/ou dermatológica, e, métodos para o tratamento cosmético da pele, para o tratamento cosmético de sinais cutâneos de envelhecimento e/ou fotoenvelhecimento e para o tratamento cosmético para prevenir e/ou tratar substâncias queratinosas secas
ES2330291B1 (es) Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
WO2005102252A3 (de) Haut- und/oder haarmittel enthaltend verbindungen mit isoprenoider struktur
WO2008139122A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
ES2243801T3 (es) Equivalente de piel/cabello con papilas reconstruidas.
EA200801717A1 (ru) Композиция местного применения по уходу за кожей, продукт на ее основе и способ лечения
DE60121549D1 (de) Echinacea-extrakt als antireizendes und alterungsschutzmittel für kosmetika
EP1667699A4 (en) Lotus and methyl donors
WO2010024608A3 (ko) 콜라겐 펩티드를 함유하는 피부미용 개선용 조성물
WO2008134712A3 (en) Use of matrix metalloproteinase inhibitors in skin care
WO2013139965A3 (en) Exopolysaccharide for the treatment and/or care of the skin, mucous membranes and/or nails
EA200970154A1 (ru) Косметические или дерматологические препараты, содержащие n-ацетилцистеин
WO2009044279A3 (en) Peptides having antimicrobial and/or biosurfactant properties
WO2015031971A3 (en) A composition comprising guacatonga extract and aroeira extract, use thereof for preventing and/or treating skin ageing
WO2011059324A3 (en) Composition for topical application, uses thereof, applicator device and kit of parts
WO2008145692A3 (en) Cosmetic composition comprising an active agent capable of stimulating tensin 1 expression
GEP20125432B (en) Improved testosterone gel and use thereof
WO2008122517A3 (en) Sunscreen compositions comprising a random terpolymer
WO2008015342A3 (fr) Utilisation d'un extrait vegetal en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes
MXPA02002117A (es) Uso de productos leguminosos para el tratamiento de agresiones externas.
BRPI0512841A (pt) composições e métodos para o tratamento de infecções patológicas
WO2010117709A3 (en) Peptide-based systems for delivery of costmetic agents
TW200719920A (en) Topical skin care composition
WO2006018454A3 (de) Kosmetische zubereitung mit hyaluronsäure und saponinen zur behandlung von hautalterungserscheinungen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2313 DE 05-05-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.